Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1995
05/17/1995EP0652888A1 INHIBITION OF $i(CANDIDA)
05/17/1995EP0652887A1 New derivatives of neuraminic acid
05/17/1995EP0652863A1 Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune diseases and tumour progression
05/17/1995EP0652768A1 Preparation for activation of natural killer cells (nk-cells), said preparation containing interferon-alpha and histamine, serotonin or substances with corresponding receptor activity
05/17/1995EP0652767A1 Treatment of human lactation failure
05/17/1995EP0652766A1 Human growth hormone aqueous formulation
05/17/1995EP0652765A1 Des-tyr dynorphin analogues
05/17/1995EP0652764A1 Use of synthetic peptides to induce tolerance to pathogenic t and b cell epitopes of autoantigens
05/17/1995EP0652758A1 Diphtheria toxin vaccines
05/17/1995EP0652756A1 Pharmaceutical compositions and use of dilinoleoylphosphatidylcholine (dlpc) for treatment and prevention of cirrhosis and fibrosis in the liver
05/17/1995EP0652731A1 Composition of low type iii content human placental collagen
05/17/1995EP0506792B1 Insulin preparations containing nicotinic acid or nicotinamide
05/17/1995EP0486520B1 Dynorphin analogs specific for kappa opioid receptors
05/17/1995EP0482185A4 Cell internalizable conjugates and complexes including intracellularly cleavable moieties
05/17/1995EP0274482B1 Compositions and methods for clones containing dna sequences associated with multidrug resistance in human cells
05/17/1995CA2135711A1 Cyclic amino acid derivatives
05/16/1995US5416202 Such as gelonin, cysteine substitution
05/16/1995US5416195 Polypeptide derivatives of granulocyte colony stimulating factor
05/16/1995US5416194 Extracted from horseshoe crab
05/16/1995US5416192 Epithelins: novel cysteine-rich growth modulating proteins
05/16/1995US5416191 Bradykinin antagonists
05/16/1995US5416117 Cyclopropenone derivatives
05/16/1995US5416093 Dipeptide derivatives
05/16/1995US5416091 Agents for potentiating the effects of antitumor agents and combating multiple drug resistance
05/16/1995US5416074 Artificial biological membrane
05/16/1995US5416073 Replacements and derivatives of terminal amino acid residues increased milk production in cows
05/16/1995US5416071 Erythropoietin
05/16/1995US5416070 Composition for macrophage activation
05/16/1995US5416021 Fibronectin binding protein-encoding DNA
05/16/1995US5416013 DNA sequences of polypeptides from genetic engineering
05/16/1995US5416006 Modification of plasminogen activators
05/16/1995CA1335622C Bradykinin analogs containing a non-peptide bond
05/16/1995CA1335577C Superoxide dismutase analogs having novel binding properties
05/16/1995CA1335569C Agents and procedures for provoking an immune response to gnrh and immuno sterilizing mammals
05/16/1995CA1335568C Cosmetic and skin treatment compositions
05/16/1995CA1335567C Lipid metabolism promoting agent
05/12/1995CA2135139A1 Topical antibacterial preparation
05/11/1995WO1995012681A1 Methods relating to ir-95
05/11/1995WO1995012678A2 Improvements relating to cancer therapy
05/11/1995WO1995012675A1 A fusion protein and method for making and using same
05/11/1995WO1995012674A1 Human kunitz-type protease inhibitors
05/11/1995WO1995012673A1 Receptor on the surface of activated t-cells: acts-4
05/11/1995WO1995012670A1 Opioid receptor: compositions and methods
05/11/1995WO1995012666A1 Human foam cells and methods for preparing them, monoclonal antibodies to said foam cells and their pharmaceutical and diagnostic use
05/11/1995WO1995012660A2 Recombinant p53 adenovirus methods and compositions
05/11/1995WO1995012618A1 A ligand capable of binding to the adenosine deaminase binding-site of cd26
05/11/1995WO1995012616A1 Nucleic acid molecules encoding kappa3 opioid receptors, receptors encoded thereby, and uses thereof
05/11/1995WO1995012615A1 Antihaemostatic agents from necator americanus
05/11/1995WO1995012614A1 Cd6 ligand
05/11/1995WO1995012612A1 Substituted di- and tripeptide inhibitors of protein:farnesyl transferase
05/11/1995WO1995012611A1 Endothelin receptor antagonists
05/11/1995WO1995012609A1 Process for producing a virus-inactivated factor viii-containing fraction by chromatographic methods
05/11/1995WO1995012581A1 Pseudodipeptide product having an imidazole grouping and applications
05/11/1995WO1995012416A1 Treatment for rheumatoid arthritis
05/11/1995WO1995012415A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions
05/11/1995WO1995012414A1 Novel modified pf4 compositions and methods of use
05/11/1995WO1995012412A1 Platelet-specific chimeric immunoglobulin and methods of use therefor
05/11/1995WO1995012408A1 Plasmin-independent fibrinolysis
05/11/1995WO1995012407A1 A pharmaceutical composition for the treatment of coronary thrombosis
05/11/1995WO1995012406A1 Use of urinastatin-like compounds to prevent premature delivery
05/11/1995WO1995012405A1 Method and composition for treatment of patients having decompensated liver disease
05/11/1995WO1995012394A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
05/11/1995WO1995012392A1 Biochemically active agents for chemical catalysis and cell receptor activation
05/11/1995WO1995012309A1 NUCLEIC ACIDS ENCODING [His?5, Trp7, Tyr8¿]-GnRH PREPROHORMONE AND [Ser8]-GnRH PREPROHORMONE AND THEIR USES
05/11/1995WO1995008628A3 Nucleic acids encoding merosin, merosin fragments and uses thereof
05/11/1995CA2175922A1 Methods relating to ir-95
05/11/1995CA2175902A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions
05/11/1995CA2175467A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
05/11/1995CA2175457A1 Treatment for rheumatoid arthritis
05/11/1995CA2175328A1 Use of urinastatin-like compounds to prevent premature delivery
05/11/1995CA2175247A1 Cd6 ligand
05/11/1995CA2175214A1 Platelet-specific chimeric immunoglobulin and methods of use therefor
05/11/1995CA2174244A1 Biochemically active agents for chemical catalysis and cell receptor activation
05/11/1995CA2173875A1 Endothelin receptor antagonists
05/11/1995CA2170766A1 Substituted di- and tripeptide inhibitors of protein:farnesyl transferase
05/10/1995EP0670729A4 Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs.
05/10/1995EP0652290A1 Method for regulation of NF-kB
05/10/1995EP0652232A1 P53as protein and antibody therefor
05/10/1995EP0652231A1 NON-TOXIC RIBOSOME INACTIVATING PROTEINS (RIPs) WITH TWO CHAINS, PROCESS FOR THE PREPARATION THEREOF AND APPLICATIONS
05/10/1995EP0652230A1 Biologically active bactericidal/permeability-increasing protein fragments
05/10/1995EP0652228A1 Urethanes and ureas that induce cytokine production
05/10/1995EP0652225A1 Use of D-Gluocopyranosiduronic acids and their derivatives for incorporation into pharmacologically active peptides and their salts
05/10/1995EP0652015A2 A sustained release composition comprising a multivalent cation cross-linked algenate combined with a polyacrylic acid
05/10/1995EP0652014A1 Treatment of prostatic hypertrophy
05/10/1995EP0652011A1 Prophylactic and remedy for viral diseases in respiratory tract
05/10/1995EP0652009A1 Identification and use of protease inhibitors
05/10/1995EP0651995A1 Cyclosporin(s) containing O/W emulsion for oral administration
05/10/1995EP0651818A1 Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding
05/10/1995EP0651811A1 $i(K. LACTIS) RP28 RIBOSOMAL PROTEIN GENE PROMOTER AND USE THEREOF
05/10/1995EP0651810A1 K. lactis pyruvate-decarboxylase promoter gene and use thereof
05/10/1995EP0651807A1 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
05/10/1995EP0651805A1 Method of intracellular binding of target molecules
05/10/1995EP0651802A1 Polypeptides having serotoninergic receptor activity (5ht6), nucleic acids coding for said polypeptides, and uses thereof
05/10/1995EP0651801A1 Polypeptides having serotoninergique activity (5ht5a), nucleic acids coding for these polypeptides and uses thereof
05/10/1995EP0651800A1 Basophil granule proteins
05/10/1995EP0651799A1 Fibrin binding domain polypeptides and uses and methods of producing same
05/10/1995EP0651793A1 Dna sequences used in the production of recombinant human bssl/cel in transgenic non-human mammals, and the produced bssl/cel used in infant formulas
05/10/1995EP0651770A1 Antihemophilic factor stabilization
05/10/1995EP0651769A1 Leukaemia inhibitory factor-binding protein
05/10/1995EP0651768A1 USE OF p97 AND IRON BINDING PROTEINS AS DIAGNOSTIC AND THERAPEUTIC AGENTS
1 ... 2847 2848 2849 2850 2851 2852 2853 2854 2855 2856 2857 2858 2859 2860 2861 2862 2863 2864 2865 2866 2867 ... 3163